J.P. Morgan Comments On Henry Schein (HSIC)

J.P. Morgan commented on Henry Schein HSIC in a research report published this morning. J.P. Morgan has previously given Henry Schein a Neutral rating. In the report, J.P. Morgan states, "This morning, HSIC reported 4Q10 EPS of $1.00, which was above our estimate of $0.94 and Bloomberg consensus of $0.96. On a y/y basis, EPS from continuing operations grew 7.6%. The EPS beat versus our expectations was entirely driven by lower net income attributable to non-controlling interests, as operating income and other below-the-line items were essentially in line. The company reaffirmed the initial 2011 guidance, despite recent commentary out of Patterson on weak dental equipment trends." Shares of Henry Schein were trading at $68.00 at the time of posting, down 2.65% from last Friday's market close.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingsHealth CareHealth Care DistributorsJ.P. Morgan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!